作者：
Samuel,Frank [1]
;
Claudia M,Testa [2]
;
Jody,Goldstein [3]
;
Elise,Kayson [3]
;
Blair R,Leavitt [4]
;
David,Oakes [5]
;
Christine,O'Neill [6]
;
Jacquelyn,Whaley [7]
;
Nicholas,Gross [8]
;
Nayla,Chaijale [9]
;
Steve,Barash [8]
;
Mark Forrest,Gordon [10]
;
Huntington Study Group/ARC-HD Investigators and Coordinators
作者单位：
Beth Israel Deaconess Medical Center/Harvard Medical School, 330 Brookline Ave., Kirstein 228, Boston, MA, 02215, USA. sfrank2@bidmc.harvard.edu.
[1]
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
[2]
Huntington Study Group, Rochester, NY, USA.
[3]
Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
[4]
University of Rochester, Rochester, NY, USA.
[5]
Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA.
[6]
Center for Health and Technology, University of Rochester, Rochester, NY, USA.
[7]
Innovative Medicines, Global Statistical and Data Sciences, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.
[8]
Global Medical Affairs, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.
[9]
Innovative Medicines and Global Clinical Development, Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA.
[10]
DOI
10.1007/s40263-024-01139-3
PMID
39825184
发布时间
2025-01-17
换一批
换一批
